€IUSQ
Šio fondo tikslas – atkartoti „MSCI All Country World Index“ (ACWI) indeksą, kuris apima didelės ir vidutinės kapitalizacijos akcijas iš 23 išsivysčiusių ir 24 besivystančių rinkų visame pasaulyje.
Vardas ar pavadinimas | Svoris | Rinkos kapitalizacija | Kaina | Dienos pokytis |
|---|---|---|---|---|
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
Legend Biotech $LEGNSveikata | 0 % | - | ||
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
Redeia €REDUtilities | 0 % | - | ||
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
Amrize AG Fr. AMRZMedžiagos | 0 % | - | ||
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
Valterra Platinum Limited £VALTMedžiagos | 0 % | - | ||
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A |